Purchasing guide and price update for Lucius version of Ripotinib in Laos

Reputinib is a tyrosine kinase inhibitor (TKI) that specifically targets ROS1, providing a new treatment option for lung cancer patients. However, the high price of original drugs makes it unaffordable for many patients. At this time, the Lao Lucious version of the generic version of repotinib has become an affordable alternative. To ensure that you purchase genuine products, it is recommended that patients purchase through formal channels, such as consulting overseas medical institutions or going to pharmaceutical factories in person. During the purchase process, carefully check the packaging, instructions, production date and anti-counterfeiting label of the medicine to ensure that the information is complete and correct. The price of the Lao Lucious version of Ripotinib is about more than 3,000 yuan, with a specification of 40mg*60 tablets, but the price may change due to market supply and exchange rate fluctuations. In short, you need to be careful when purchasing, ensure that the source of the medicine is formal and the information is correct to ensure the safety and effectiveness of the treatment.

References:

https://www.drugs.com/newdrugs/fda-approves-augtyro-repotrectinib-locally-advanced-metastatic-ros1-positive-non-small-cell-lung-6145.html